188 related articles for article (PubMed ID: 18466265)
21. Impulsive and compulsive behaviors in Parkinson's disease.
Evans AH; Strafella AP; Weintraub D; Stacy M
Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
[TBL] [Abstract][Full Text] [Related]
22. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
Rascol O
Eur J Neurol; 2011 Mar; 18 Suppl 1():3-10. PubMed ID: 21255197
[TBL] [Abstract][Full Text] [Related]
23. Neuropsychological findings in a case of punding before and after cessation of pramipexole.
Larson ER
Clin Neuropsychol; 2015; 29(1):166-78. PubMed ID: 25658417
[TBL] [Abstract][Full Text] [Related]
24. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
[TBL] [Abstract][Full Text] [Related]
25. Panic attack like episodes possibly associated with pramipexole therapy in Parkinson's disease.
Alonso-Navarro H; Jiménez-Jiménez FJ
Eur J Neurol; 2007 May; 14(5):e1. PubMed ID: 17437590
[No Abstract] [Full Text] [Related]
26. Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.
Ohno H; Nakajima M; Fujioka S; Iwamoto K; Kawamura M
J Clin Neurosci; 2009 Jun; 16(6):790-2. PubMed ID: 19286385
[TBL] [Abstract][Full Text] [Related]
27. Switching from pergolide to pramipexole in patients with Parkinson's disease.
Hanna PA; Ratkos L; Ondo WG; Jankovic J
J Neural Transm (Vienna); 2001; 108(1):63-70. PubMed ID: 11261747
[TBL] [Abstract][Full Text] [Related]
28. Hiccups in Parkinson's disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature.
Lertxundi U; Marquínez AC; Domingo-Echaburu S; Solinís MÁ; Calvo B; Del Pozo-Rodríguez A; García M; Aguirre C; Isla A
Eur J Clin Pharmacol; 2017 Sep; 73(9):1159-1164. PubMed ID: 28600702
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Pramipexole-Induced Problematic Sexual Behaviors.
Murphy L; Ly T; DiMario K; Mihowich T; Fedoroff JP
Prim Care Companion CNS Disord; 2021 Feb; 23(1):. PubMed ID: 34000142
[TBL] [Abstract][Full Text] [Related]
30. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
[TBL] [Abstract][Full Text] [Related]
31. [Aripiprazole, gambling disorder and compulsive sexuality].
Mété D; Dafreville C; Paitel V; Wind P
Encephale; 2016 Jun; 42(3):281-3. PubMed ID: 26923999
[TBL] [Abstract][Full Text] [Related]
32. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease.
Politis M; Loane C; Wu K; O'Sullivan SS; Woodhead Z; Kiferle L; Lawrence AD; Lees AJ; Piccini P
Brain; 2013 Feb; 136(Pt 2):400-11. PubMed ID: 23378222
[TBL] [Abstract][Full Text] [Related]
33. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Klos KJ; Bower JH; Josephs KA; Matsumoto JY; Ahlskog JE
Parkinsonism Relat Disord; 2005 Sep; 11(6):381-6. PubMed ID: 16109498
[TBL] [Abstract][Full Text] [Related]
34. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
Seeman P
Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960
[TBL] [Abstract][Full Text] [Related]
35. [Severe leg edema associated with the use of dopaminergic drugs in Parkinson's disease. Report of one case].
Miranda C M; Hudson A L
Rev Med Chil; 2017 Dec; 145(12):1624-1625. PubMed ID: 29652961
[TBL] [Abstract][Full Text] [Related]
36. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
Molho ES; Factor SA; Weiner WJ; Sanchez-Ramos JR; Singer C; Shulman L; Brown D; Sheldon C
J Neural Transm Suppl; 1995; 45():225-30. PubMed ID: 8748629
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for the development of pedal edema in patients using pramipexole.
Kleiner-Fisman G; Fisman DN
Arch Neurol; 2007 Jun; 64(6):820-4. PubMed ID: 17420306
[TBL] [Abstract][Full Text] [Related]
38. [Stealing as an Impulse Control Disorder Associated with Pramipexole - A Case Report from Forensic Psychiatric Practice].
Clemm von Hohenberg C; Dreßing H
Psychiatr Prax; 2017 Apr; 44(3):172-174. PubMed ID: 28399600
[TBL] [Abstract][Full Text] [Related]
39. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.
Driver-Dunckley ED; Noble BN; Hentz JG; Evidente VG; Caviness JN; Parish J; Krahn L; Adler CH
Clin Neuropharmacol; 2007; 30(5):249-55. PubMed ID: 17909302
[TBL] [Abstract][Full Text] [Related]
40. Pramipexole safely replaces ergot dopamine agonists with either rapid or slow switching.
Takahashi H; Nogawa S; Tachibana H; Kawamura J; Abe T; Ogino Y; Kashihara K; Hamada T; Kowa H;
J Int Med Res; 2008; 36(1):106-14. PubMed ID: 18230274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
